XML 42 R34.htm IDEA: XBRL DOCUMENT
v3.25.2

Collaboration Revenue (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2025 | Jun. 30, 2024 | Jun. 30, 2025 | Jun. 30, 2024
Revenues |  |  |  |
Total collaboration revenue | $ 8 | $ 4 | $ 82 | $ 49
Other Collaboration Revenue |  |  |  |
Revenues |  |  |  |
Total collaboration revenue |  |  | 5 |
Farxiga: sales milestones |  |  |  |
Revenues |  |  |  |
Total collaboration revenue |  |  | $ 77 | $ 49

X
- Definition The amount of revenue arising from transactions involving the Company's medicines as well as medicine the Company has acquired an interest in. Such income included upfront consideration, milestones receipts and royalties, as well as other income from collaborations. + References No definition available. + Details
Name: | azn_CollaborationRevenue
Namespace Prefix: | azn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=azn_OtherCollaborationRevenueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=azn_FarxigaSalesMilestonesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |